1. Home
  2. OFIX vs KALV Comparison

OFIX vs KALV Comparison

Compare OFIX & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFIX
  • KALV
  • Stock Information
  • Founded
  • OFIX 1987
  • KALV N/A
  • Country
  • OFIX United States
  • KALV United States
  • Employees
  • OFIX N/A
  • KALV N/A
  • Industry
  • OFIX Medical/Dental Instruments
  • KALV Biotechnology: Pharmaceutical Preparations
  • Sector
  • OFIX Health Care
  • KALV Health Care
  • Exchange
  • OFIX Nasdaq
  • KALV Nasdaq
  • Market Cap
  • OFIX 648.7M
  • KALV 563.1M
  • IPO Year
  • OFIX N/A
  • KALV N/A
  • Fundamental
  • Price
  • OFIX $16.06
  • KALV $11.93
  • Analyst Decision
  • OFIX Strong Buy
  • KALV Strong Buy
  • Analyst Count
  • OFIX 4
  • KALV 8
  • Target Price
  • OFIX $23.33
  • KALV $24.83
  • AVG Volume (30 Days)
  • OFIX 237.2K
  • KALV 619.3K
  • Earning Date
  • OFIX 05-06-2025
  • KALV 03-12-2025
  • Dividend Yield
  • OFIX N/A
  • KALV N/A
  • EPS Growth
  • OFIX N/A
  • KALV N/A
  • EPS
  • OFIX N/A
  • KALV N/A
  • Revenue
  • OFIX $799,491,000.00
  • KALV N/A
  • Revenue This Year
  • OFIX $5.39
  • KALV N/A
  • Revenue Next Year
  • OFIX $6.56
  • KALV N/A
  • P/E Ratio
  • OFIX N/A
  • KALV N/A
  • Revenue Growth
  • OFIX 7.08
  • KALV N/A
  • 52 Week Low
  • OFIX $12.08
  • KALV $7.30
  • 52 Week High
  • OFIX $20.73
  • KALV $15.50
  • Technical
  • Relative Strength Index (RSI)
  • OFIX 35.40
  • KALV 54.49
  • Support Level
  • OFIX $16.45
  • KALV $11.83
  • Resistance Level
  • OFIX $17.00
  • KALV $12.58
  • Average True Range (ATR)
  • OFIX 0.47
  • KALV 0.59
  • MACD
  • OFIX -0.03
  • KALV -0.12
  • Stochastic Oscillator
  • OFIX 14.39
  • KALV 22.40

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

Share on Social Networks: